Patrick Taylor Horn
Technik-/Wissenschafts-/F&E-Leiter bei FULCRUM THERAPEUTICS, INC.
Aktive Positionen von Patrick Taylor Horn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FULCRUM THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.03.2024 | - |
Karriereverlauf von Patrick Taylor Horn
Ehemalige bekannte Positionen von Patrick Taylor Horn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALBIREO PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 | 31.12.2021 |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Corporate Officer/Principal | 01.01.2018 | 01.07.2018 |
TETRAPHASE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.01.2011 | 29.12.2017 |
DYAX CORP. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2010 | 01.12.2010 |
ABBOTT LABORATORIES | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.01.2006 |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Patrick Taylor Horn
The University of Chicago | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Pritzker School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Schweiz | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Health Technology |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
- Börse
- Insiders
- Patrick Taylor Horn
- Erfahrung